Statistics
Publications
8
Citations
1.4K
H-Index
8
Active since
2006
Attila Paczal is an author at Servier (France) specializing in medicinal chemistry, drug discovery, and pharmacology.
Publications per year
2006–2021
8
8
The MCL1 inhibitor S63845 is tolerable and effective in diverse cancer models
András Kotschy, Zoltán Szlávik, James B. Murray et al. · Nature · 2016 · 1.1K citations
Medicine, Oncology, Pharmacology +11
Discovery of S64315, a Potent and Selective Mcl-1 Inhibitor
Zoltán Szlávik, Márton Csékei, Attila Paczal et al. · Journal of Medicinal Chemistry · 2020 · 106 citations · Full text
Structure-Guided Discovery of Potent and Selective DYRK1A Inhibitors
Csaba Weber, Melinda Sipos, Attila Paczal et al. · Journal of Medicinal Chemistry · 2021 · 34 citations · Full text
1–5 of 8